ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $215,000 | +18.8% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $181,000 | -13.4% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $209,000 | -2.8% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $215,000 | -39.4% | 42,000 | -52.8% | 0.00% | -50.0% |
| Q2 2019 | $355,000 | +34.0% | 89,000 | +263.3% | 0.00% | 0.0% |
| Q1 2019 | $265,000 | +22.7% | 24,500 | -44.9% | 0.00% | +100.0% |
| Q4 2018 | $216,000 | -18.5% | 44,500 | +81.6% | 0.00% | -50.0% |
| Q3 2018 | $265,000 | -9.9% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $294,000 | +14.4% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $257,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |